June 13, 2022Yan’an BikangPublished a progress announcement on investor litigation matters. It can be seen from this: the company recently received the “Civil Judgment” (2021) Shaan 01 Min Chu No. 71, (2021) Shaan 01 Min Chu No. 514, (2021) Shaan 01 Civil Chu No. 519, (2021) Shaan 01 Minchu No. 522, (2021) Shaan 01 Minchu No. 528, (2021) Shaan 01 Minchu No. 591, (2021) Shaan 01 Minchu No. 826, (2021) Shaan 01 Min No. 830 at the beginning of the year. According to the “Civil Judgment”, the Intermediate People’s Court of Xi’an City, Shaanxi Province has concluded the trial of eight natural person investors including Fu Daoxun and the company’s securities misrepresentation liability disputes.
The reporter saw from the “Civil Judgment” (2021) Shaan 01 Min Chu No. 71: The plaintiff’s claims include ordering the defendant Yan’an Bikang Company to compensate the plaintiff Fu Daoxun for economic losses of 1,072,242 yuan, commission of 321 yuan, stamp duty of 1,072 yuan, totaling 1,073,635 yuan Yuan. In accordance with relevant regulations, the Intermediate People’s Court of Xi’an City, Shaanxi Province ruled that the defendant, Yan’an Bikang Pharmaceutical Co., Ltd., should compensate the plaintiff Fu Daoxun for economic losses of RMB 937,932.8 within ten days from the date of this judgment.
It can be seen that with the confirmation of the company’s illegal facts, investors whose rights and interests have been damaged have begun to defend their rights, and the lawsuit has been supported by the court. According to relevant judicial interpretations, those who bought during the period from April 26, 2016 to March 25, 2020 and sold after March 26, 2020 or are still held and have incurred a certain floating loss (regardless of whether they are released or not) Investors can protect their legitimate rights and interests through legal channels.You can also send your name, contact number, and transaction history (an Excel file is recommended) to[email protected]to participate in the collection of claims organized by the “Private Rights Protection” column of “Securities Market Red Weekly”. Investors participating in this activity do not need to pay any attorney fees before obtaining compensation, and the final claim conditions and compensation shall be subject to the court judgment.
Regarding the illegal facts of the company, it can be seen from the previous announcement: 1. There are major omissions in the relevant annual reports, and the non-operating capital occupation of the controlling shareholder and its related parties is not disclosed; 2. There are false records in the relevant annual reports and false increases Monetary funds; 3. The information disclosed in the relevant interim reports is inaccurate and incomplete, and there are misleading statements. The above-mentioned illegal facts are proved by relevant announcements, situation explanations, contracts and agreements, accounting materials, bank materials, records of inquiries of relevant parties and other evidences, which are sufficient to be determined.
In this regard, the Shaanxi Supervision Bureau decided: Yan’an Bikang Pharmaceutical Co., Ltd. was ordered to make corrections, given a warning and fined 600,000 yuan; Li Zongsong was given a warning and a fine of 600,000 yuan; Xiang Xingfu and Gu Xiaojia were given a warning and a fine of 600,000 yuan. A fine of 300,000 yuan was imposed respectively; Zhou Xinji, Dong Wen, and Wu Anjun were given a warning and a fine of 100,000 yuan respectively; Liu Ou, Deng Qing, Du Qiong, Huang Hui, Du Jie, Chai Yina, Zheng Shaogang, Shao Haiquan, Zhu Jianjun, Lei Ping Sen, He Yudong, Liu Yuming, Guo Jun, Xia Jianhua, Chen Bing, Li Jingkun, Su Xi, Chen Junming, and Wang Zhaoyu were given warnings and fined 30,000 yuan each.
The reporter noticed that as of April 29, 2022, the closing price of Yan’an Bikang was 6.55 yuan. Next, we will continue to track the progress of relevant events, and small and medium investors who meet the rights protection conditions can also make rights protection claims through relevant legal channels.
The private rights protection column of “Securities Market Red Weekly” provides investors with securities rights protection, shareholder litigation and other related consulting and services, so that investors who have suffered losses due to listed companies’ violations can protect themselves through legal channels without having to invest any lawyers’ fees in the early stage. legitimate rights and interests.
We only wish to use the power of the media to solve problems for the majority of investors on the road to safeguard their rights.
Investors who want to participate in the rights protection collection activities of listed companies can send their names, contact information and transaction records of rights protection stocks to the mailbox:
Or directly add a column WeChat account to submit rights protection information:
Rights consultation telephone number:18500204922/010-85651425
For more details on rights protection stocks, please visit:
Massive information, accurate interpretation, all in Sina Finance APP